SELLAS Life Sciences Group, Inc. Stock Issued During Period, Shares, Restricted Stock Award, Gross
SELLAS Life Sciences Group, Inc. (SLS) reported Stock Issued During Period, Shares, Restricted Stock Award, Gross of 1.32 million shares for the 6-month period ending 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross · last filed 2014-03-17
- 2012-09-30: Stock Issued During Period, Shares, Restricted Stock Award, Gross 6 month 1.32M shares.
- 2012-06-30: Stock Issued During Period, Shares, Restricted Stock Award, Gross 6 month 1.32M shares.
- 2012-01-19: Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month 1.32M shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month | Stock Issued During Period, Shares, Restricted Stock Award, Gross 6 month |
|---|---|---|
| 2012-09-30 | 1.32M shares 10-Q · filed 2012-11-13 | |
| 2012-06-30 | 1.32M shares 10-Q · filed 2012-08-14 | |
| 2012-01-19 | 1.32M shares 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |